We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$7.23B
AUM Growth
+$298M
(+4.3%)
Cap. Flow
+$149M
Cap. Flow
% of AUM
2.07%
Top 10 Holdings %
Top 10 Hldgs %
15.39%
Holding
1,100
New
151
Increased
415
Reduced
333
Closed
164
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$40.6M |
| 2 |
Autodesk
ADSK
|
+$38.8M |
| 3 |
Intuit
INTU
|
+$37.1M |
| 4 |
Ecolab
ECL
|
+$35.6M |
| 5 |
Coca-Cola
KO
|
+$35.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$51.9M |
| 2 |
EOG Resources
EOG
|
+$33.8M |
| 3 |
DATA
Tableau Software, Inc.
DATA
|
+$32M |
| 4 |
Microsoft
MSFT
|
+$29.8M |
| 5 |
Ford
F
|
+$29.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.67% |
| 2 | Financials | 17.68% |
| 3 | Consumer Discretionary | 13.74% |
| 4 | Industrials | 11.53% |
| 5 | Healthcare | 11.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRSN
701
DELISTED
Mersana Therapeutics
MRSN
| $676K | 0.01% |
+6,675
| New | +$786K |
|
702
CMS Energy
CMS
$23.1B
| $675K | 0.01% |
11,664
| – | – |
|
|
BDN
703
Brandywine Realty Trust
BDN
$551M
| $660K | 0.01% |
46,100
-75,215
| -62% | -$1.15M |
|
704
Lands' End
LE
$361M
| $640K | 0.01% |
+52,341
| New | +$791K |
|
705
Methode Electronics
MEI
$543M
| $639K | 0.01% |
22,380
-190
| -0.8% | -$5.32K |
|
|
TCS
706
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $639K | 0.01% |
+5,819
| New | +$703K |
|
707
Univest Financial
UVSP
$1.23B
| $628K | 0.01% |
23,900
-5,200
| -18% | -$130K |
|
708
Terreno Realty
TRNO
$7.68B
| $619K | 0.01% |
+12,620
| New | +$572K |
|
709
OneMain Financial
OMF
$6.9B
| $618K | 0.01% |
18,280
| – | – |
|
710
Lexicon Pharmaceuticals
LXRX
$1.02B
| $614K | 0.01% |
97,642
-70,123
| -42% | -$420K |
|
|
ELVT
711
DELISTED
Elevate Credit, Inc.
ELVT
| $614K | 0.01% |
149,113
-13,517
| -8% | -$60.3K |
|
|
CCXI
712
DELISTED
ChemoCentryx, Inc.
CCXI
| $613K | 0.01% |
65,890
+14,700
| +29% | +$170K |
|
713
W&T Offshore
WTI
$545M
| $612K | 0.01% |
123,300
+18,600
| +18% | +$100K |
|
714
Micron Technology
MU
$1.04T
| $610K | 0.01% |
15,799
-76,041
| -83% | -$2.9M |
|
715
E.W. Scripps
SSP
$274M
| $607K | 0.01% |
39,682
-100
| -0.3% | -$1.87K |
|
716
Fossil Group
FOSL
$239M
| $600K | 0.01% |
+52,200
| New | +$641K |
|
717
Glaukos
GKOS
$9.02B
| $597K | 0.01% |
+7,920
| New | +$568K |
|
718
Hooker Furnishings Corp
HOFT
$148M
| $594K | 0.01% |
+28,813
| New | +$775K |
|
|
IPHS
719
DELISTED
Innophos Holdings, Inc.
IPHS
| $592K | 0.01% |
20,335
-140
| -0.7% | -$4.19K |
|
|
PPLI
720
People Inc
PPLI
$3.1B
| $587K | 0.01% |
15,108
| – | – |
|
721
ATN International
ATNI
$361M
| $578K | 0.01% |
10,006
-60
| -0.6% | -$3.6K |
|
722
Amplify Energy
AMPY
$163M
| $568K | 0.01% |
96,451
+14,960
| +18% | +$132K |
|
|
CHUY
723
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $565K | 0.01% |
+24,645
| New | +$530K |
|
724
Haemonetics
HAE
$3.58B
| $561K | 0.01% |
4,660
+1,460
| +46% | +$144K |
|
725
Saia
SAIA
$11.3B
| $553K | 0.01% |
8,550
-23,100
| -73% | -$1.48M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2019 Portfolio in Review
As of Q2 2019, Jacobs Levy Equity Management held 1,100 positions worth $7.23B, up 4.3% from $6.93B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Jacobs Levy Equity Management's Q2 2019 filing shows 151 new, 415 increased, 333 reduced and 164 closed positions. Its largest new stake was Biogen: 175,817 shares worth $41.1M. The largest sale was Allergan plc, an estimated $51.9M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q2 2019 buy was Biogen: 175,817 shares worth $41.1M.
- Jacobs Levy Equity Management added most to Ecolab in Q2 2019, an estimated $35.6M increase.
- Jacobs Levy Equity Management's biggest Q2 2019 reduction was EOG Resources, cutting an estimated $33.8M.
- Jacobs Levy Equity Management fully exited Allergan plc in Q2 2019, selling an estimated $51.9M.
- Jacobs Levy Equity Management's ten largest holdings make up 15% of its $7.23B portfolio in Q2 2019.
- Jacobs Levy Equity Management opened 151 new positions and closed 164 in Q2 2019.
- Jacobs Levy Equity Management's portfolio value rose 4.3% quarter-over-quarter to $7.23B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2019, filed 13 Aug 2019.